T2L

Welcome to the Brand page for “T2L”, which is offered here for T two l; t to l;pharmaceutical research and development services; assay optimization and miniaturization, method development, high throughput screening, high throughput confirmation and dose response, deconvolution of complex samples, synthetic chemistry, medicinal chemistry, compound logistics, purification, analytics and computational chemistry for early drug discovery research and development;.

Its status is currently believed to be active. Its class is unavailable. “T2L” is believed to be currently owned by “ICAGEN, INC.”


Owner:
ICAGEN, INC.
Owner Details
Description:
T TWO L; T TO L;Pharmaceutical research and development services; assay optimization and miniaturization, method development, high throughput screening, high throughput confirmation and dose response, deconvolution of complex samples, synthetic chemistry, medicinal chemistry, compound logistics, purification, analytics and computational chemistry for early drug discovery research and development;
Categories: T TWO L